by MM360 Staff | May 15, 2025 | Uncategorized
Source: CureToday articles Robotic and minimally invasive kidney cancer surgery may reduce pain, shorten recovery time and preserve kidney function, according to Dr. Armine Smith. Read More
by MM360 Staff | May 15, 2025 | Uncategorized
Source: CureToday articles The FDA has approved Zynyz as a first-line treatment in combination with chemo and as a single-agent following progression in advanced anal cancer. Read More
by MM360 Staff | May 15, 2025 | Uncategorized
Source: CureToday articles As a patient with CLL, I’ve found comfort in teddy bears — first as a chaplain offering solace, now as a patient embracing their quiet presence myself. Read More
by MM360 Staff | May 15, 2025 | Uncategorized
Source: CureToday articles Efti plus Keytruda and chemo achieved a 61% response rate in first-line advanced non-squamous non–small cell lung cancer, outperforming historical data. Read More
by MM360 Staff | May 15, 2025 | Uncategorized
Source: CureToday articles The FDA approved the Ventana MET RxDx assay, making it the first companion diagnostic to aid in determining MET protein expression in non-squamous NSCLC. Read More
by MM360 Staff | May 15, 2025 | Uncategorized
Source: CureToday articles Lumakras plus Vectibix showed improved overall survival and response rates in KRAS G12C metastatic colorectal cancer, though not statistically significant. Read More
